Chief Strategy Officer and Board appointments

AI SummaryClose X

Allergy Therapeutics plc has announced the appointments of Helge Weiner-Trapness as Chief Strategy Officer and Executive Director, and Lawrence Allen Wang as Independent Non-Executive Director, effective January 30, 2026. Helge Weiner-Trapness brings over 30 years of experience from global investment banks, including HSBC Holdings plc, and will focus on driving the company's long-term international growth strategy, corporate development, and partnership strategy. Lawrence Allen Wang, with over 20 years in healthcare and investment roles, including CFO of Adicon Clinical Laboratories, Inc., will strengthen the board's expertise as the company pursues its ambition to become a global leader in allergy treatments and evaluates a potential dual listing on the Hong Kong Stock Exchange. Neither appointee currently holds shares in the company.

Disclaimer*

UK 100

Latest directors dealings